Page 14 - Andreaf Wainer News Today

Brown Financial Advisory acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,904 shares of the healthcare product maker’s stock, valued at approximately $210,000. Other hedge funds have also […]

Harbour Trust & Investment Management Co purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 42,989 shares of the healthcare product maker’s stock, valued at approximately $4,732,000. A number of other […]

Aull & Monroe Investment Management Corp trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,551 shares of the healthcare product maker’s stock after selling 553 shares during the quarter. […]

Equitable Trust Co. cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 23,453 shares of the healthcare product maker’s stock after selling 952 shares during the quarter. Equitable Trust Co.’s holdings in Abbott Laboratories were worth $2,581,000 as of its most […]

Eastern Bank decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 10.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 38,652 shares of the healthcare product maker’s stock after selling 4,325 shares during the quarter. Eastern Bank’s holdings in Abbott Laboratories were […]

Busey Bank increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 15.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,024 shares of the healthcare product maker’s stock after acquiring an additional 12,740 shares during the quarter. Busey Bank’s holdings […]

Benin Management CORP trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,063 shares of the healthcare product maker’s stock after selling 245 shares during the quarter. Benin […]

Grant Street Asset Management Inc. bought a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,081 shares of the healthcare product maker’s stock, valued at approximately $229,000. A number of other […]

O Brien Wealth Partners LLC acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 758 shares of the healthcare product maker’s stock, valued at approximately $83,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in […]

O Brien Wealth Partners LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 758 shares of the healthcare product maker’s stock, valued at approximately $83,000. A number of other institutional investors […]